<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/wp-content/plugins/xml-sitemap-feed/assets/sitemap-news.xsl?ver=5.7.7"?>
<!-- generated-on="2026-09-09T22:35:12+00:00" -->
<!-- generator="XML Sitemap & Google News for WordPress" -->
<!-- generator-url="https://status301.net/wordpress-plugins/xml-sitemap-feed/" -->
<!-- generator-version="5.7.7" -->
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" >
<url><loc>https://www.magpatients.org/vevizye-ciclosporine-traitement-secheresse-oculaire/</loc><news:news><news:publication><news:name>MagPatients</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-09-09T15:54:29+02:00</news:publication_date><news:title>Vevizye : ciclosporine pour traiter la sécheresse oculaire</news:title></news:news></url>
<url><loc>https://www.magpatients.org/cancer-sein-hotesse-maladie-professionnelle/</loc><news:news><news:publication><news:name>MagPatients</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-09-09T10:19:46+02:00</news:publication_date><news:title>Cancer du sein reconnu en maladie professionnelle à Bayonne</news:title></news:news></url>
<url><loc>https://www.magpatients.org/enflonsia-clesrovimab-prevention-vrs-nourrissons/</loc><news:news><news:publication><news:name>MagPatients</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-09-09T09:50:04+02:00</news:publication_date><news:title>Enflonsia : l’alternative au Beyfortus pour prévenir le VRS</news:title></news:news></url>
<url><loc>https://www.magpatients.org/rupture-stock-atropine-faure-rappel/</loc><news:news><news:publication><news:name>MagPatients</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-09-08T14:54:55+02:00</news:publication_date><news:title>Rupture stock Atropine Faure : état des lieux et sécurité</news:title></news:news></url>
<url><loc>https://www.magpatients.org/tirzepatide-traitement-saos-obesite/</loc><news:news><news:publication><news:name>MagPatients</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-09-08T10:06:00+02:00</news:publication_date><news:title>Traitement de l’apnée du sommeil par GLP-1 et tirzépatide</news:title></news:news></url>
</urlset>
